key: cord-0832870-4xgypq6v
authors: Khanna, Sahil
title: Gut Involvement by COVID-19
date: 2020-09-24
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.09.029
sha: 64fd9ccc47d3a476f382e8f6be1856fa3991b34e
doc_id: 832870
cord_uid: 4xgypq6v

nan

the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was a respiratory pathogen mediated by its affinity to the angiotensin-converting enzyme 2 (ACE-2) receptor. As our understanding of COVID-19 evolved, it became clear that SARS-CoV-2 leads to gastrointestinal signs and symptoms, owing to the ubiquitous presence of the ACE-2 receptor in the human gut.

The gastrointestinal effects are seen due to ACE-2 expression on small intestine and colonic enterocytes, hepatocytes and cholangiocytes.

Gastrointestinal manifestations of SARS-CoV-2 including anorexia, nausea, vomiting, diarrhea and hepato-cellular injury (manifesting as transaminitis) have been widely reported. A recent systematic-review and meta-analysis of 78 studies with 12,797 patients reported that loss of appetite with a prevalence of 22.3% was the most common gastrointestinal symptoms. Other symptoms such as diarrhea was reported in 12.4%, nausea and/or vomiting was seen in 9.0% and abdominal pain occurred in 6.2% 1 . Another meta-analysis demonstrated that the pooled prevalence estimates of transaminitis was 15% 2 . These two large reviews demonstrate that studies from China report a lower prevalence of gastrointestinal symptoms and abnormalities compared to studies from other countries. This lower prevalence could be related to lack of adequate reporting of systemic symptoms in studies from China, as SARS-CoV-2 was initially J o u r n a l P r e -p r o o f thought to be a respiratory illness. In the midst of the beginnings of a global pandemic, gathering and reporting all data can be a legitimate challenge; indeed, significant heterogeneity exists among the studies included in these systematic reviews. Studies have demonstrated that gastrointestinal symptoms may be present before respiratory symptoms and sometimes even in the absence of respiratory symptoms. The emergence of these data has led to amendment of screening and diagnostic protocols for COVID-19, with the inclusion of gastrointestinal symptoms to testing algorithms. It is now being recommended that patients presenting with these common gastrointestinal symptoms should undergo a thorough assessment for exposure to and presence of other non-gastrointestinal symptoms of COVID-19.

A bigger debate and concern center on the detection of SARS-CoV-2 in stool and the role of With data being inconclusive, there is a need for frequent air exchanges and consideration of installation of negative pressure systems while taking care of patients with COVID-19, especially while performing aerosol generating procedures. Another implication of these emerging data is the risk of transmission of SARS-CoV-2 for a commonly done procedure for recurrent Clostridioides difficile infection, namely, fecal microbiota transplantation (FMT). Clostridioides difficile infection is the commonest bacterial infection in hospitals with high morbidity and mortality. Recurrent C difficile is extremely common with the risk being over 60% after three or more infections. Fecal microbiota transplantation reduces the risk of recurrent C difficile to less than 15%, owing to restoration of a disrupted microbiome. In 2020, microbiota-based therapies such as FMT are dependent on procurement of donor stool from well-screened donors ruling out microbiome-associated diseases and infections. With the potential transmission of SARS-CoV-2 from stool and the presence of asymptomatic carriage, donors need to be reliably tested for the presence of SARS-CoV-2 10 .

Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Metaanalysis

AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring

Post-lockdown detection of SARS-CoV-2 RNA in the wastewater of

Sewage analysis as a tool for the COVID-19 pandemic response and management: the urgent need for optimised protocols for SARS-CoV-2 detection and quantification

COVID-19 and Gastrointestinal Symptoms